Aarey Drugs Pharmaceuticals Ltd vs Panjon Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 87.07 as of 12 May 15:30 . The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 8.3 on March 2021 to 23.9 on March 2025 . This represents a CAGR of 23.56% over 5 yearsThe P/E Ratio of Panjon Ltd changed from 22.4 on March 2023 to 97.8 on March 2025 . This represents a CAGR of 63.44% over 3 years The Market Cap of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 54.25 crore on March 2021 to ₹ 95.58 crore on March 2025 . This represents a CAGR of 11.99% over 5 yearsThe Market Cap of Panjon Ltd changed from ₹ 27.28 crore on March 2022 to ₹ 38.6 crore on March 2025 . This represents a CAGR of 9.07% over 4 years The revenue of Aarey Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 100.61 crore as compare to the Sep '25 revenue of ₹ 84.95 crore. This represent the growth of 18.43% The revenue of Panjon Ltd for the Dec '25 is ₹ 14.18 crore as compare to the Sep '25 revenue of ₹ 14.99 crore. This represent the decline of -5.4% The ebitda of Aarey Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 2.67 crore as compare to the Sep '25 ebitda of ₹ 3.44 crore. This represent the decline of -22.38% The ebitda of Panjon Ltd for the Dec '25 is ₹ 0.33 crore as compare to the Sep '25 ebitda of ₹ 0.31 crore. This represent the growth of 6.45% The net profit of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 1.24 crore to ₹ 0.57 crore over 7 quarters. This represents a CAGR of -35.86% The net profit of Panjon Ltd changed from ₹ 0.03 crore to ₹ 0.22 crore over 7 quarters. This represents a CAGR of 212.22% The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Panjon Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Limited was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Private Limited.
The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the Company and it was converted into public limited company.
Also, the name of the company was changed from Niharika Textiles & Chemicals Private Limited to Aarey Drugs & Pharmaceuticals Limited. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

About Panjon Ltd

Panjon Limited was incorporated on 28 March, 1990 as Panjon Private Limited and subsequently converted into a public limited company on November 7, 1992.
Initially, the Company engaged in the manufacturing & trading of consumer and pharmaceutical products.
It marked the presence with significant achievements, which command a remarkable market status. Panjon has renowned products like PANJON Tablet , PANJON Balm , PANJON Inhaler, PANJON cough drops, Swad Digestive Drops, Swad Chatpati Drops, Swad Chyawanpra Candy,Percy Masala Candy, Panjon Swad PACHAK range : Shahi Anardana, Special Jeera Goli, Hing Peda, Albela Aam, Khatta Meetha Khajoor, Chatpata Amla, Chulbuli Imli and many more. The company came out with a public issue in Nov.'93 at a premium of Rs 15 to part-finance its proposed expansion and upgradation programme.

FAQs for the comparison of Aarey Drugs & Pharmaceuticals Ltd and Panjon Ltd

Which company has a larger market capitalization, Aarey Drugs & Pharmaceuticals Ltd or Panjon Ltd?

Market cap of Aarey Drugs & Pharmaceuticals Ltd is 258 Cr while Market cap of Panjon Ltd is 38 Cr

What are the key factors driving the stock performance of Aarey Drugs & Pharmaceuticals Ltd and Panjon Ltd?

The stock performance of Aarey Drugs & Pharmaceuticals Ltd and Panjon Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarey Drugs & Pharmaceuticals Ltd and Panjon Ltd?

As of May 12, 2026, the Aarey Drugs & Pharmaceuticals Ltd stock price is INR ₹91.0. On the other hand, Panjon Ltd stock price is INR ₹22.6.

How do dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Panjon Ltd compare?

To compare the dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Panjon Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.